Ensign Peak Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.11M | Sell |
53,320
-1,780
| -3% | -$70.3K | ﹤0.01% | 880 |
|
|
2025
Q1 | $1.66M | Buy |
55,100
+1,780
| +3% | +$53.7K | ﹤0.01% | 988 |
|
|
2024
Q4 | $1.86M | Sell |
53,320
-16,560
| -24% | -$579K | ﹤0.01% | 969 |
|
|
2024
Q3 | $2.8M | Buy |
69,880
+1,610
| +2% | +$64.5K | ﹤0.01% | 813 |
|
|
2024
Q2 | $3.25M | Buy |
68,270
+14,950
| +28% | +$713K | 0.01% | 750 |
|
|
2024
Q1 | $2.31M | Buy |
53,320
+7,010
| +15% | +$304K | ﹤0.01% | 866 |
|
|
2023
Q4 | $2.34M | Hold |
46,310
| – | – | ﹤0.01% | 849 |
|
|
2023
Q3 | $2.1M | Hold |
46,310
| – | – | ﹤0.01% | 826 |
|
|
2023
Q2 | $1.9M | Hold |
46,310
| – | – | ﹤0.01% | 899 |
|
|
2023
Q1 | $1.66M | Sell |
46,310
-8,581
| -16% | -$307K | ﹤0.01% | 923 |
|
|
2022
Q4 | $2.07M | Buy |
54,891
+22,576
| +70% | +$853K | ﹤0.01% | 798 |
|
|
2022
Q3 | $1.43M | Buy |
32,315
+7,445
| +30% | +$329K | ﹤0.01% | 911 |
|
|
2022
Q2 | $921K | Hold |
24,870
| – | – | ﹤0.01% | 1151 |
|
|
2022
Q1 | $921K | Sell |
24,870
-3,460
| -12% | -$128K | ﹤0.01% | 1254 |
|
|
2021
Q4 | $862K | Buy |
+28,330
| New | +$862K | ﹤0.01% | 1365 |
|
|
2021
Q1 | – | Sell |
-4,882
| Closed | -$276K | – | 1857 |
|
|
2020
Q4 | $276K | Sell |
4,882
-5,198
| -52% | -$294K | ﹤0.01% | 1686 |
|
|
2020
Q3 | $478K | Buy |
+10,080
| New | +$478K | ﹤0.01% | 1538 |
|
|
2020
Q1 | – | Sell |
-5,574
| Closed | -$337K | – | 1660 |
|
|
2019
Q4 | $337K | Buy |
+5,574
| New | +$337K | ﹤0.01% | 1577 |
|